Anhydrous Copper Complex Manufacturing for Neuromuscular Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for neuromuscular diseases such as muscular dystrophy, multiple sclerosis, and rheumatoid arthritis are either ineffective or come with significant side effects, and there is a need for cost-effective and widely available therapeutic options for these conditions.
Innovation Solution
A method for producing an anhydrous copper complex (C12H10ClCuN2O4) comprising chlorobis copper(I) complex, copper ascorbate, and ascorbic acid, which can be administered as a pharmaceutical or dietary supplement to treat various neuromuscular diseases and physical ailments, including muscle weakness, neurological impairments, and chronic inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments for neuromuscular diseases are used, then some therapeutic effect is achieved, but significant side effects occur and effectiveness is limited
Solution Approach 1:
The patent changes the chemical parameters by using a specific anhydrous copper complex with defined stoichiometry (Cu:ascorbic acid:nicotinic acid = 1:2:2) and controlled water content (≤1%), which modifies the therapeutic profile to achieve better effectiveness with reduced side effects compared to conventional treatments
Solution Approach 2:
The invention uses a composite pharmaceutical composition containing multiple components (copper complex, ascorbic acid, nicotinic acid, and excipients) that work synergistically to treat neuromuscular diseases, providing improved therapeutic effects while minimizing harmful side effects
2Reliability
If existing therapeutic methodologies are applied, then some symptoms are alleviated, but the treatments are costly and difficult to obtain
Solution Approach 1:
The patent employs inexpensive, readily available materials including copper chloride, ascorbic acid, and nicotinic acid that can be manufactured at low cost, making the treatment economically accessible and widely available compared to expensive biologics and stem cell therapies
Solution Approach 2:
The invention optimizes manufacturing parameters including reaction temperature (40-60°C), reaction time (2-4 hours), and solvent composition to enable simple, scalable production that reduces manufacturing costs and improves availability
3Object-affected harmful factors
If current pharmaceutical treatments are used, then neurological impairments are partially addressed, but the treatments only alleviate symptoms or delay progression without curing the underlying disease
Solution Approach 1:
The copper complex acts as an intermediary that facilitates multiple biological functions including antioxidant activity, anti-inflammatory effects, and neuroprotection, addressing underlying disease mechanisms rather than merely alleviating symptoms
Solution Approach 2:
The multi-component composition works synergistically to address multiple pathogenic mechanisms simultaneously (oxidative stress, inflammation, mitochondrial dysfunction), providing disease-modifying effects rather than just symptomatic relief
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The copper complex promotes muscle growth, nerve regeneration, and enhanced athletic performance, reduces post-traumatic healing time, and provides effective symptom relief for a range of conditions, including muscle weakness, neurological impairments, and chronic inflammation, with potential synergistic effects when combined with other therapies.
Implementation Method 1
A method of making an anhydrous copper complex comprising the steps of: combining cuprous chloride, ascorbic acid and nicotinic acid in aqueous ethanol to form a reaction mixture
Implementation Method 2
combining cuprous chloride, ascorbic acid and nicotinic acid in aqueous ethanol to form a reaction mixture, allowing the reaction mixture to stand at a temperature of from 40° C. to 60° C. for a period of from 2 hours to 4 hours
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A method of manufacturing an anhydrous copper complex of formula C12H10CICuN2O4 and methods of treating neuromuscular and other diseases, including but not limited to fibromyalgia, multiple sclerosis, muscular dystrophy, rheumatoid arthritis, pain, fatigue, sleeplessness, loss of fine motor control, speech loss, inflexibility, Alzheimer's, dementia, amyotrophic lateral sclerosis, depression, lyme disease, lyme disease co-infection, gastroparesis (GP), myopathy, chronic inflammation and/or incontinence. The anhydrous copper complex preferably is administered in a pharmaceutical and/or dietary supplement composition of the invention.